Cardinal Glennon Childrens Hospital Dialysis is a medicare approved dialysis facility center in Saint Louis, Missouri and it has 4 dialysis stations. It is located in Saint Louis City county at 1465 S Grand Blvd, Saint Louis, MO, 63104. You can reach out to the office of Cardinal Glennon Childrens Hospital Dialysis at (314) 268-6423. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Cardinal Glennon Childrens Hospital Dialysis has the following ownership type - Non-Profit. It was first certified by medicare in March, 1985. The medicare id for this facility is 263300 and it accepts patients under medicare ESRD program.
| Name | Cardinal Glennon Childrens Hospital Dialysis |
|---|---|
| Location | 1465 S Grand Blvd, Saint Louis, Missouri |
| No. of Dialysis Stations | 4 |
| Medicare ID | 263300 |
| Managed By | Independent |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 1465 S Grand Blvd, Saint Louis, Missouri, 63104 | |
| (314) 268-6423 | |
| Not Available |
News Archive
"The global cases of Guinea worm disease have plunged to another new all-time low, former President Jimmy Carter said Thursday, bringing health workers closer to their goal of eradicating the disease," the Canadian Press reports.
The University Jaume I (UJI) has patented a new fluorescent chemical sensor that is capable of detecting citric acid at low concentrations more rapidly and cheaply than the current optical sensors.
Methods from optogenetics and machine learning should help improve treatment options for stroke patients. Researchers from Heidelberg University have developed a computer vision technique to analyze the changes in motor skills that result from targeted stimulation of healthy areas of the brain.
A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.
Silencing genes that have malfunctioned is an important approach for treating diseases such as cancer and heart disease. One effective approach is to deliver drugs made from small molecules of ribonucleic acid, or RNA, which are used to inhibit gene expression. The drugs, in essence, mimic a natural process called RNA interference.
› Verified 8 days ago
| Dialysis patients with Hemoglobin data | 6 |
News Archive
"The global cases of Guinea worm disease have plunged to another new all-time low, former President Jimmy Carter said Thursday, bringing health workers closer to their goal of eradicating the disease," the Canadian Press reports.
The University Jaume I (UJI) has patented a new fluorescent chemical sensor that is capable of detecting citric acid at low concentrations more rapidly and cheaply than the current optical sensors.
Methods from optogenetics and machine learning should help improve treatment options for stroke patients. Researchers from Heidelberg University have developed a computer vision technique to analyze the changes in motor skills that result from targeted stimulation of healthy areas of the brain.
A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.
Silencing genes that have malfunctioned is an important approach for treating diseases such as cancer and heart disease. One effective approach is to deliver drugs made from small molecules of ribonucleic acid, or RNA, which are used to inhibit gene expression. The drugs, in essence, mimic a natural process called RNA interference.
› Verified 8 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Percentage of adult patients getting regular hemodialysis at the center | |
| Pediatic patients getting regular hemodialysis at the center | 7 |
| Pediatric patient months included in in Kt/V greater than or eqaul to 1.2 | 47 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
"The global cases of Guinea worm disease have plunged to another new all-time low, former President Jimmy Carter said Thursday, bringing health workers closer to their goal of eradicating the disease," the Canadian Press reports.
The University Jaume I (UJI) has patented a new fluorescent chemical sensor that is capable of detecting citric acid at low concentrations more rapidly and cheaply than the current optical sensors.
Methods from optogenetics and machine learning should help improve treatment options for stroke patients. Researchers from Heidelberg University have developed a computer vision technique to analyze the changes in motor skills that result from targeted stimulation of healthy areas of the brain.
A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.
Silencing genes that have malfunctioned is an important approach for treating diseases such as cancer and heart disease. One effective approach is to deliver drugs made from small molecules of ribonucleic acid, or RNA, which are used to inhibit gene expression. The drugs, in essence, mimic a natural process called RNA interference.
› Verified 8 days ago
| Adult patients getting regular peritoneal dialysis at the center | 1 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 6 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Pediatric patients getting regular peritoneal dialysis at the centre | 6 |
| Pediatric patient months included in Kt/V greater than or equal to 1.7 | 47 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
"The global cases of Guinea worm disease have plunged to another new all-time low, former President Jimmy Carter said Thursday, bringing health workers closer to their goal of eradicating the disease," the Canadian Press reports.
The University Jaume I (UJI) has patented a new fluorescent chemical sensor that is capable of detecting citric acid at low concentrations more rapidly and cheaply than the current optical sensors.
Methods from optogenetics and machine learning should help improve treatment options for stroke patients. Researchers from Heidelberg University have developed a computer vision technique to analyze the changes in motor skills that result from targeted stimulation of healthy areas of the brain.
A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.
Silencing genes that have malfunctioned is an important approach for treating diseases such as cancer and heart disease. One effective approach is to deliver drugs made from small molecules of ribonucleic acid, or RNA, which are used to inhibit gene expression. The drugs, in essence, mimic a natural process called RNA interference.
› Verified 8 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Cardinal Glennon Childrens Hospital Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 1 |
| Hypercalcemia patient months | 6 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
| Patients with Serumphosphor | 1 |
| Patients with Serumphosphor less than 3.5 mg/dL | |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | |
| Patients with Serumphosphor greater than 7 mg/dL |
News Archive
"The global cases of Guinea worm disease have plunged to another new all-time low, former President Jimmy Carter said Thursday, bringing health workers closer to their goal of eradicating the disease," the Canadian Press reports.
The University Jaume I (UJI) has patented a new fluorescent chemical sensor that is capable of detecting citric acid at low concentrations more rapidly and cheaply than the current optical sensors.
Methods from optogenetics and machine learning should help improve treatment options for stroke patients. Researchers from Heidelberg University have developed a computer vision technique to analyze the changes in motor skills that result from targeted stimulation of healthy areas of the brain.
A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.
Silencing genes that have malfunctioned is an important approach for treating diseases such as cancer and heart disease. One effective approach is to deliver drugs made from small molecules of ribonucleic acid, or RNA, which are used to inhibit gene expression. The drugs, in essence, mimic a natural process called RNA interference.
› Verified 8 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 10 |
| Hospitalization Rate in facility | 284.6 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 692.2 |
| Hospitalization Rate: Lower Confidence Limit | 125.5 |
News Archive
"The global cases of Guinea worm disease have plunged to another new all-time low, former President Jimmy Carter said Thursday, bringing health workers closer to their goal of eradicating the disease," the Canadian Press reports.
The University Jaume I (UJI) has patented a new fluorescent chemical sensor that is capable of detecting citric acid at low concentrations more rapidly and cheaply than the current optical sensors.
Methods from optogenetics and machine learning should help improve treatment options for stroke patients. Researchers from Heidelberg University have developed a computer vision technique to analyze the changes in motor skills that result from targeted stimulation of healthy areas of the brain.
A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.
Silencing genes that have malfunctioned is an important approach for treating diseases such as cancer and heart disease. One effective approach is to deliver drugs made from small molecules of ribonucleic acid, or RNA, which are used to inhibit gene expression. The drugs, in essence, mimic a natural process called RNA interference.
› Verified 8 days ago
The rate of readmission show you whether patients who were being treated regularly at Cardinal Glennon Childrens Hospital Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 26.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 43.9 |
| Readmission Rate: Lower Confidence Limit | 13.8 |
News Archive
"The global cases of Guinea worm disease have plunged to another new all-time low, former President Jimmy Carter said Thursday, bringing health workers closer to their goal of eradicating the disease," the Canadian Press reports.
The University Jaume I (UJI) has patented a new fluorescent chemical sensor that is capable of detecting citric acid at low concentrations more rapidly and cheaply than the current optical sensors.
Methods from optogenetics and machine learning should help improve treatment options for stroke patients. Researchers from Heidelberg University have developed a computer vision technique to analyze the changes in motor skills that result from targeted stimulation of healthy areas of the brain.
A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.
Silencing genes that have malfunctioned is an important approach for treating diseases such as cancer and heart disease. One effective approach is to deliver drugs made from small molecules of ribonucleic acid, or RNA, which are used to inhibit gene expression. The drugs, in essence, mimic a natural process called RNA interference.
› Verified 8 days ago